P2Y12 inhibitors for the neurointerventionalist.
Authors
R Hickman, Charlotte
Fuschi, Maurizio
Thibault, Lucie
Henkes, Hans
Fiorella, David
Tan, Benjamin Yq
D Makalanda, Hegoda L
Wong, Ken
Publication Date
2022-02Journal Title
Interv Neuroradiol
ISSN
1591-0199
Publisher
SAGE Publications
Volume
28
Issue
1
Pages
92-103
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Borchert, R. J., Simonato, D., R Hickman, C., Fuschi, M., Thibault, L., Henkes, H., Fiorella, D., et al. (2022). P2Y12 inhibitors for the neurointerventionalist.. Interv Neuroradiol, 28 (1), 92-103. https://doi.org/10.1177/15910199211015042
Abstract
The use of antiplatelets is widespread in clinical practice. However, for neurointerventional procedures, protocols for antiplatelet use are scarce and practice varies between individuals and institutions. This is further complicated by the quantity of antiplatelet agents which differ in route of administration, dosage, onset of action, efficacy and ischemic and hemorrhagic complications. Clarifying the individual characteristics for each antiplatelet agent, and their associated risks, will increasingly become relevant as the practice of mechanical thrombectomy, stenting, coiling and flow diversion procedures grows. The aim of this review is to summarize the existing literature for the use of P2Y12 inhibitors in neurointerventional procedures, examine the quality of the evidence, and highlight areas in need of further research.
Keywords
Reviews, Antiplatelets, hemorrhage, stroke, aneurysm, thrombectomy
Identifiers
10.1177_15910199211015042
External DOI: https://doi.org/10.1177/15910199211015042
This record's URL: https://www.repository.cam.ac.uk/handle/1810/334778
Rights
Licence:
https://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk